Glaukos Profit Margin 2014-2020 | GKOS
Current and historical gross margin, operating margin and net profit margin for Glaukos (GKOS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Glaukos net profit margin as of June 30, 2020 is -33.55%.
|Glaukos Annual Profit Margins
|Glaukos Quarterly Profit Margins
||Medical Instruments Manufacturing
Glaukos Corporation is an ophthalmic medical technology company. The Company develops, manufactures and markets medical devices for the treatment of glaucoma. Its product pipeline consists of iStent Inject, the iStent Supra and iDose. The company operates primarily in United States, Germany, Europe, the Asia Pacific, Canada and internationally. Glaukos Corporation is headquartered in Laguna Hills, California.